Cargando…

Molecular modeling of LDLR aids interpretation of genomic variants

ABSTRACT: Genetic variants in low-density lipoprotein receptor (LDLR) are known to cause familial hypercholesterolemia (FH), occurring in up to 1 in 200 people (Youngblom E. et al. 1993 and Nordestgaard BG et al. 34:3478–3490a, 2013) and leading to significant risk for heart disease. Clinical genomi...

Descripción completa

Detalles Bibliográficos
Autores principales: Klee, Eric W., Zimmermann, Michael T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440939/
https://www.ncbi.nlm.nih.gov/pubmed/30778614
http://dx.doi.org/10.1007/s00109-019-01755-3
_version_ 1783407454237753344
author Klee, Eric W.
Zimmermann, Michael T.
author_facet Klee, Eric W.
Zimmermann, Michael T.
author_sort Klee, Eric W.
collection PubMed
description ABSTRACT: Genetic variants in low-density lipoprotein receptor (LDLR) are known to cause familial hypercholesterolemia (FH), occurring in up to 1 in 200 people (Youngblom E. et al. 1993 and Nordestgaard BG et al. 34:3478–3490a, 2013) and leading to significant risk for heart disease. Clinical genomics testing using high-throughput sequencing is identifying novel genomic variants of uncertain significance (VUS) in individuals suspected of having FH, but for whom the causal link to the disease remains to be established (Nordestgaard BG et al. 34:3478–3490a, 2013). Unfortunately, experimental data about the atomic structure of the LDL binding domains of LDLR at extracellular pH does not exist. This leads to an inability to apply protein structure-based methods for assessing novel variants identified through genetic testing. Thus, the ambiguities in interpretation of LDLR variants are a barrier to achieving the expected clinical value for personalized genomics assays for management of FH. In this study, we integrated data from the literature and related cellular receptors to develop high-resolution models of full-length LDLR at extracellular conditions and use them to predict which VUS alter LDL binding. We believe that the functional effects of LDLR variants can be resolved using a combination of structural bioinformatics and functional assays, leading to a better correlation with clinical presentation. We have completed modeling of LDLR in two major physiologic conditions, generating detailed hypotheses for how each of the 1007 reported protein variants may affect function. KEY MESSAGES: • Hundreds of variants are observed in the LDLR, but most lack interpretation. • Molecular modeling is aided by biochemical knowledge. • We generated context-specific 3D protein models of LDLR. • Our models allowed mechanistic interpretation of many variants. • We interpreted both rare and common genomic variants in their physiologic context. • Effects of genomic variants are often context-specific. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00109-019-01755-3) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6440939
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-64409392019-04-15 Molecular modeling of LDLR aids interpretation of genomic variants Klee, Eric W. Zimmermann, Michael T. J Mol Med (Berl) Original Article ABSTRACT: Genetic variants in low-density lipoprotein receptor (LDLR) are known to cause familial hypercholesterolemia (FH), occurring in up to 1 in 200 people (Youngblom E. et al. 1993 and Nordestgaard BG et al. 34:3478–3490a, 2013) and leading to significant risk for heart disease. Clinical genomics testing using high-throughput sequencing is identifying novel genomic variants of uncertain significance (VUS) in individuals suspected of having FH, but for whom the causal link to the disease remains to be established (Nordestgaard BG et al. 34:3478–3490a, 2013). Unfortunately, experimental data about the atomic structure of the LDL binding domains of LDLR at extracellular pH does not exist. This leads to an inability to apply protein structure-based methods for assessing novel variants identified through genetic testing. Thus, the ambiguities in interpretation of LDLR variants are a barrier to achieving the expected clinical value for personalized genomics assays for management of FH. In this study, we integrated data from the literature and related cellular receptors to develop high-resolution models of full-length LDLR at extracellular conditions and use them to predict which VUS alter LDL binding. We believe that the functional effects of LDLR variants can be resolved using a combination of structural bioinformatics and functional assays, leading to a better correlation with clinical presentation. We have completed modeling of LDLR in two major physiologic conditions, generating detailed hypotheses for how each of the 1007 reported protein variants may affect function. KEY MESSAGES: • Hundreds of variants are observed in the LDLR, but most lack interpretation. • Molecular modeling is aided by biochemical knowledge. • We generated context-specific 3D protein models of LDLR. • Our models allowed mechanistic interpretation of many variants. • We interpreted both rare and common genomic variants in their physiologic context. • Effects of genomic variants are often context-specific. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00109-019-01755-3) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2019-02-18 2019 /pmc/articles/PMC6440939/ /pubmed/30778614 http://dx.doi.org/10.1007/s00109-019-01755-3 Text en © The Author(s) 2019 OpenAccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Klee, Eric W.
Zimmermann, Michael T.
Molecular modeling of LDLR aids interpretation of genomic variants
title Molecular modeling of LDLR aids interpretation of genomic variants
title_full Molecular modeling of LDLR aids interpretation of genomic variants
title_fullStr Molecular modeling of LDLR aids interpretation of genomic variants
title_full_unstemmed Molecular modeling of LDLR aids interpretation of genomic variants
title_short Molecular modeling of LDLR aids interpretation of genomic variants
title_sort molecular modeling of ldlr aids interpretation of genomic variants
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440939/
https://www.ncbi.nlm.nih.gov/pubmed/30778614
http://dx.doi.org/10.1007/s00109-019-01755-3
work_keys_str_mv AT kleeericw molecularmodelingofldlraidsinterpretationofgenomicvariants
AT zimmermannmichaelt molecularmodelingofldlraidsinterpretationofgenomicvariants